Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2013; 19(12): 1943-1952
Published online Mar 28, 2013. doi: 10.3748/wjg.v19.i12.1943
Published online Mar 28, 2013. doi: 10.3748/wjg.v19.i12.1943
Factors | EVR | Non-EVR | P value1 |
Patient sociodemographics | |||
Age (yr), mean ± SD | 43.9 ± 9.7 | 47.0 ± 10.0 | < 0.005 |
Sex | |||
Male | 602 (86) | 101 (14) | NS |
Female | 264 (89) | 33 (11) | |
Origin | |||
Developed country | 64 (93) | 5 (7) | NS |
Developing country | 801 (86) | 129 (14) | |
Race | |||
Caucasian | 836 (87) | 130 (14) | NS |
Other | 24 (89) | 3 (11) | |
Educational level | |||
Equivalent to or less than high | 537 (86) | 85 (14) | NS |
Professional training | 209 (87) | 31 (13) | |
University or higher | 119 (88) | 17 (13) | |
Marital status | |||
Single | 235 (85) | 41 (15) | NS |
Married | 491 (86) | 81 (14) | |
Separated/divorced/widowed | 135 (92) | 12 (8) | |
Family status | |||
Lives alone | 82 (85) | 15 (16) | NS |
Lives with another person | 769 (87) | 117 (13) | |
Clinical characteristics | |||
Weight (kg), mean ± SD | 75.6 ± 13.4 | 77.2 ± 13.5 | NS |
Alcohol consumption | |||
No | 731 (86) | 115 (14) | NS |
Yes | 133 (88) | 19 (13) | |
Tobacco consumption | |||
No | 414 (85) | 75 (15) | NS |
Yes | 450 (88) | 59 (12) | |
Source of HCV infection | |||
Injection drug use | 221 (90) | 26 (11) | NS |
Transfusion | 126 (89) | 16 (11) | |
IV route | 79 (87) | 12 (13) | |
Other | 435 (85) | 78 (15) | |
Methadone replacement therapy | |||
No | 803 (86) | 126 (14) | NS |
Yes | 57 (89) | 7 (11) | |
ALT (IU/mL), mean ± SD | 86.3 ± 69.4 | 101.7 ± 71.5 | < 0.05 |
AST (IU/mL), mean ± SD | 72.1 ± 65.3 | 84.8 ± 58.5 | < 0.05 |
GGT (IU/mL), mean ± SD | 73.6 ± 85.2 | 134.0 ± 114.4 | < 0.001 |
Ferritin (μg/L), mean ± SD | 248.0 ± 268.8 | 388.8 ± 357.3 | < 0.001 |
Cirrhosis | |||
No | 817 (88) | 112 (12) | < 0.001 |
Yes | 41 (67) | 20 (33) | |
HCV genotype | |||
1/4 | 645 (84) | 126 (16) | < 0.001 |
2/3 | 214 (96) | 8 (4) | |
HCV-RNA (IU/mL), mean ± SD | 3 354 135.6 ± 5 978 359.9 | 3 781 940.0 ± 4 780 000.6 | NS |
Baseline viral load | |||
< 400 000 IU/mL | 237 (91) | 25 (10) | < 0.05 |
≥ 400 000 IU/mL | 623 (85) | 109 (15) |
- Citation: García-Samaniego J, Romero M, Granados R, Alemán R, Jorge Juan M, Suárez D, Pérez R, Castellano G, González-Portela C. Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C. World J Gastroenterol 2013; 19(12): 1943-1952
- URL: https://www.wjgnet.com/1007-9327/full/v19/i12/1943.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i12.1943